ACCESSION: MSBNK-SMB_Measured-HSA001P0216002
RECORD_TITLE: Characterized; 1-(2-piperazin-1-ylethyl)piperazine; LC-ESI-QFT; MS2; POSITIVE; generated fron DDA dataset
DATE: 2025.04.02 (Averaged 2025.02.14, Processed 2025.02.21, Annotated 2025.04.02, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was characterized at Level 3 automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyushu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 13
COMMENT: RAW_SPEC {'BLK01_7565': {'bp': 702603.0, 'sum': 1991683.0}, 'BLK01_7353': {'bp': 694853.0, 'sum': 1926251.0}, 'BLK01_7290': {'bp': 691404.0, 'sum': 1929375.0}, 'BLK01_7502': {'bp': 650311.0, 'sum': 1800459.0}, 'BLK01_7441': {'bp': 614906.0, 'sum': 1682640.0}, 'BLK01_7839': {'bp': 610427.0, 'sum': 1652390.0}, 'BLK01_7628': {'bp': 591159.0, 'sum': 1605149.0}, 'BLK01_7761': {'bp': 576640.0, 'sum': 1625009.0}, 'BLK01_7692': {'bp': 542486.0, 'sum': 1507078.0}, 'BLK01_7900': {'bp': 503637.0, 'sum': 1457814.0}, 'BLK01_7977': {'bp': 495956.0, 'sum': 1358576.0}, 'BLK02_7472': {'bp': 441364.0, 'sum': 1122304.0}, 'BLK02_7662': {'bp': 413810.0, 'sum': 1115332.0}}
COMMENT: RETENTION_TIME_STDEV 0.420
COMMENT: PRECURSOR_M/Z_RAW 216.217763
COMMENT: PRECURSOR_M/Z_STDEV 0.000079
COMMENT: PRECURSOR_IN_MS1 mz 216.218144; int 117.379; delta(ppm) 1.096905
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M+H; M+NH4; mz 233.244697; int 411.471; cor 0.923
COMMENT: PROPOSED_ION_FORM M+H; M+ACN+H; mz 257.244663; int 169.127; cor 0.731
COMMENT: PROPOSED_ION_FORM M+H; M+2ACN+H; mz 298.271326; int 89.608; cor 0.835
COMMENT: PROPOSED_ION_FORM M+NH4; M+2ACN+H; mz 281.244713; int 17.626; cor 0.692
COMMENT: PROPOSED_ION_FORM M+Na; M+ACN+Na; mz 257.244663; int 169.127; cor 0.731
COMMENT: PROPOSED_ION_FORM M+ACN+H; M+2ACN+H; mz 257.244663; int 169.127; cor 0.731
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.599; C10H25N5; [M+H]+; delta(ppm) -0.599412
COMMENT: PROPOSED_MF SevenGoldenRules 0.641; C10H22N4; [M+NH4]+; delta(ppm) -0.640818
COMMENT: PROPOSED_MF SevenGoldenRules 0.729; C8H22N4; [M+ACN+H]+; delta(ppm) -0.729113
COMMENT: PROPOSED_MF MS-FINDER 2.795; C10H22N4; [M+NH4]+; delta(ppm) -0.597851
COMMENT: PROPOSED_MF MS-FINDER 2.587; C8H22N4; [M+ACN+H]+; delta(ppm) 74670.647753
COMMENT: PROPOSED_MF MS-FINDER 2.140; C10H25N5; [M+H]+; delta(ppm) -0.597851
COMMENT: PROPOSED_MF SIRIUS5_Sirius 26.607; C10H22N4; [M+H3N+H]+; delta(ppm) -0.597851
COMMENT: PROPOSED_MF SIRIUS5_Sirius 26.607; C8H22N4; [M+C2H3N+H]+; delta(ppm) -0.597851
COMMENT: PROPOSED_MF SIRIUS5_Sirius 26.607; C10H25N5; [M+H]+; delta(ppm) -0.597851
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C8H22N4; [M+C2H3N+H]+; delta(ppm) -0.597851
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C10H25N5; [M+H]+; delta(ppm) -0.597851
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C10H22N4; [M+H3N+H]+; delta(ppm) -0.597851
COMMENT: PROPOSED_MF SIRIUS6_Sirius 53.945; C10H25N5; [M+H]+; delta(ppm) -0.597851
COMMENT: PROPOSED_MF SIRIUS6_Sirius 53.945; C10H22N4; [M+H3N+H]+; delta(ppm) -0.597851
COMMENT: PROPOSED_MF SIRIUS6_Sirius 53.945; C8H22N4; [M+C2H3N+H]+; delta(ppm) -0.597851
COMMENT: PROPOSED_MF SIRIUS6_Sirius 39.620; C12H27N2O; [M+H]+; delta(ppm) -6.807569
COMMENT: PROPOSED_MF SIRIUS6_Sirius 39.620; C12H24NO; [M+H3N+H]+; delta(ppm) -6.807569
COMMENT: PROPOSED_MF SIRIUS6_Sirius 39.620; C10H24NO; [M+C2H3N+H]+; delta(ppm) -6.807569
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C10H25N5; [M+H]+; delta(ppm) -0.597851
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C10H22N4; [M+H3N+H]+; delta(ppm) -0.597851
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C8H22N4; [M+C2H3N+H]+; delta(ppm) -0.597851
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.486; ACGDKVXYNVEAGU-UHFFFAOYSA-N; [M+NH4]+; Guanethidine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.085; VVZPFWHJZRAHKY-UHFFFAOYSA-N; [M+NH4]+; N-{4-[(3-methylbut-1-en-1-yl)amino]butyl}guanidine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.970; XBVKJTPKQHUYHI-UHFFFAOYSA-N; [M+ACN+H]+; N'-(2-aminoethyl)-N'-(3-aminopropyl)propane-1,3-diamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.932; SJNDFAUBUWEBDR-UHFFFAOYSA-N; [M+NH4]+; CNP0444498
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.863; RXFCIXRFAJRBSG-UHFFFAOYSA-N; [M+ACN+H]+; 3,2,3-tetramine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.786; SKGAVCHIFDRDTK-UHFFFAOYSA-N; [M+ACN+H]+; 1-Guanidinium-7-Aminoheptane
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; VVZPFWHJZRAHKY-UHFFFAOYSA-N; [M+NH4]+; N-{4-[(3-methylbut-1-en-1-yl)amino]butyl}guanidine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; XBVKJTPKQHUYHI-UHFFFAOYSA-N; [M+ACN+H]+; N'-(2-aminoethyl)-N'-(3-aminopropyl)propane-1,3-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.992; SJNDFAUBUWEBDR-UHFFFAOYSA-N; [M+NH4]+; CNP0444498
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.868; ACGDKVXYNVEAGU-UHFFFAOYSA-N; [M+NH4]+; Guanethidine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.805; RXFCIXRFAJRBSG-UHFFFAOYSA-N; [M+ACN+H]+; 3,2,3-tetramine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.784; SKGAVCHIFDRDTK-UHFFFAOYSA-N; [M+ACN+H]+; 1-Guanidinium-7-Aminoheptane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.871; ACGDKVXYNVEAGU-UHFFFAOYSA-N; [M+NH4]+; 2-[2-(azocan-1-yl)ethyl]guanidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.816; RXFCIXRFAJRBSG-UHFFFAOYSA-N; [M+ACN+H]+; N'-[2-(3-aminopropylamino)ethyl]propane-1,3-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.000; LPOUQGUYVMSQOH-UHFFFAOYSA-N; [M+H]+; N'-[2-(2-piperazin-1-ylethylamino)ethyl]ethane-1,2-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.886; KDCBVVQAMMXRFB-UHFFFAOYSA-N; [M+H]+; 1,4,7,10,13-pentazacyclopentadecane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.779; CXNQJNPKMZRHBC-UHFFFAOYSA-N; [M+H]+; N'-[2-[4-(2-aminoethyl)piperazin-1-yl]ethyl]ethane-1,2-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.500; UDRMRSLPPDGMPF-JGVFFNPUSA-N; [M+ACN+H]+; (2R)-2-N-[2-[[(2S)-2-aminopropyl]amino]ethyl]propane-1,2-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.270; NZNLWMMWMCQCIE-UHFFFAOYSA-N; [M+ACN+H]+; 1-N-[2-(2-aminopropylamino)ethyl]propane-1,2-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.208; XDHVNMPVLPEHND-UHFFFAOYSA-N; [M+NH4]+; 1-(2-piperazin-1-ylethyl)piperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.169; PQQFEOVQJBNJJF-OCAPTIKFSA-N; [M+ACN+H]+; (2S)-2-N-[2-[[(2R)-1-aminopropan-2-yl]amino]ethyl]propane-1,2-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.067; LLQZZBARQZBNEH-UHFFFAOYSA-N; [M+NH4]+; 2-[3-(3-methylpiperidin-1-yl)propyl]guanidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.063; ILZNQIXWPJXOCK-UHFFFAOYSA-N; [M+NH4]+; 2-[2-[cyclohexyl(methyl)amino]ethyl]guanidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.059; QGLNJLLUIYNAEO-DTORHVGOSA-N; [M+NH4]+; 2-[2-[(2R,6S)-2,6-dimethylpiperidin-1-yl]ethyl]guanidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.059; KDIMDNGDUIGURW-UHFFFAOYSA-N; [M+NH4]+; 2-[2-(4-methylazepan-1-yl)ethyl]guanidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.009; VACJHYSOFQSYAC-UHFFFAOYSA-N; [M+NH4]+; 1-(4-aminobutyl)-2-(3-methylbut-2-enyl)guanidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.741; LZELKEGDAZZHMY-UHFFFAOYSA-N; [M+NH4]+; N'-[8-(aminomethylideneamino)octyl]methanimidamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -13.681; XDHVNMPVLPEHND; [M+H3N+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -14.430; KDCBVVQAMMXRFB; [M+H]+; [15]anen5
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -14.811; CXNQJNPKMZRHBC; [M+H]+; N-(2-Aminoethyl)piperazin-1,4-diethylamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -17.017; RXFCIXRFAJRBSG; [M+C2H3N+H]+; 1,8,12-Tetraazadodecane
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -17.276; LPOUQGUYVMSQOH; [M+H]+; N''-[2-(2-piperazin-1-ylethylamino)ethyl]ethane-1,2-diamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -88.810; JHTHWQGESSFWFP; [M+H3N+H]+; 6-Spermyne
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -122.477; SKGAVCHIFDRDTK; [M+C2H3N+H]+; N'-(7-aminoheptyl)methanetriamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -169.387; ACGDKVXYNVEAGU; [M+H3N+H]+; Eutensol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -217.733; VACJHYSOFQSYAC; [M+H3N+H]+; N-Prenyl Agmatine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -233.773; BNYZYAWCGAEIKT; [M+H3N+H]+; Spherophysine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -249.396; QGLNJLLUIYNAEO; [M+H3N+H]+; 2-[2-(2,6-dimethylpiperidin-1-yl)ethyl]guanidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -257.334; VVZPFWHJZRAHKY; [M+H3N+H]+; 2-[4-(3-methylbut-1-enylamino)butyl]guanidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -299.185; SJNDFAUBUWEBDR; [M+H3N+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.738; XDHVNMPVLPEHND; [M+H3N+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.500; RXFCIXRFAJRBSG; [M+C2H3N+H]+; 1,8,12-Tetraazadodecane
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.240; KDCBVVQAMMXRFB; [M+H]+; [15]anen5
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -10.343; KDCBVVQAMMXRFB; [M+H]+; 1,4,7,10,13-Pentaazacyclopentadecane
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -36.151; RXFCIXRFAJRBSG; [M+C2H3N+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -37.444; XDHVNMPVLPEHND; [M+H3N+H]+; Piperazine, 1,1'-(1,2-ethanediyl)bis-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -61.068; LPOUQGUYVMSQOH; [M+H]+; N-(2-Aminoethyl)-N'-(2-(1-piperazinyl)ethyl)ethylenediamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -75.604; CXNQJNPKMZRHBC; [M+H]+; N1-(2-(4-(2-aminoethyl)piperazin-1-yl)ethyl)ethane-1,2-diamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -84.709; XBVKJTPKQHUYHI; [M+C2H3N+H]+; N~1~-(2-Aminoethyl)-N~1~-(3-aminopropyl)propane-1,3-diamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -100.439; JHTHWQGESSFWFP; [M+H3N+H]+; 2-Butyne-1,4-diamine, N,N'-bis(3-aminopropyl)-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -123.249; SKGAVCHIFDRDTK; [M+C2H3N+H]+; 1-Guanidinium-7-aminoheptane
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -182.466; VVZPFWHJZRAHKY; [M+H3N+H]+; N-{4-[(3-methylbut-1-en-1-yl)amino]butyl}guanidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -202.577; VACJHYSOFQSYAC; [M+H3N+H]+; N-(4-aminobutyl)-N'-(3-methylbut-2-en-1-yl)guanidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -204.764; ACGDKVXYNVEAGU; [M+H3N+H]+; N-[2-(azocan-1-yl)ethyl]guanidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -218.372; BNYZYAWCGAEIKT; [M+H3N+H]+; Spherophysine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -223.381; SJNDFAUBUWEBDR; [M+H3N+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -233.457; QGLNJLLUIYNAEO; [M+H3N+H]+; 2-[2-[(2S,6R)-2,6-dimethylpiperidin-1-yl]ethyl]guanidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.736; KDCBVVQAMMXRFB; [M+H]+; 1,4,7,10,13-Pentaazacyclopentadecane
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.425; RXFCIXRFAJRBSG; [M+C2H3N+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.421; XDHVNMPVLPEHND; [M+H3N+H]+; Piperazine, 1,1'-(1,2-ethanediyl)bis-
COMMENT: CONFIDENCE Level 3: Tentative candidate, 1,4,7,10,13-Pentaazacyclopentadecane, XDHVNMPVLPEHND-UHFFFAOYSA-N; Proposed by SIRIUS6_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 MetFrag:PubchemLite (8); This structural isomer was suggested from the biological context HMDB HMDB0000214;HMDB0003374;
CH$NAME: 1-(2-piperazin-1-ylethyl)piperazine
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C10H22N4
CH$EXACT_MASS: 198.184447
CH$SMILES: C1CN(CCN1)CCN2CCNCC2
CH$IUPAC: InChI=1S/C10H22N4/c1-5-13(6-2-11-1)9-10-14-7-3-12-4-8-14/h11-12H,1-10H2
CH$LINK: INCHIKEY XDHVNMPVLPEHND-UHFFFAOYSA-N
CH$LINK: PUBCHEM CID:88087
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 15.256
MS$FOCUSED_ION: ION_TYPE [M+NH4]+
MS$FOCUSED_ION: PRECURSOR_M/Z 216.218143
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-014i-1980000000-f92e2be182bb01633e25
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  70.0650023 12.9285 70.065622 1.6271 2.76 0.6455 11 f{C4H8N1}/-1.76ppm,p-C6H18N4
  72.0806629 21.2639 72.081269 1.1515 2.78 0.7582 13 f{C4H10N1}/-1.57ppm,p-C6H16N4
  85.0759176 19.3135 85.076397 0.9403 3.96 0.5440 13 f{C4H9N2}/-1.26ppm,p-C6H17N3
  86.0599725 29.5012 86.060439 1.1387 4.91 0.6264 13 ?
  87.0917007 102.3575 87.092154 0.5626 9.07 0.9505 13 f{C4H11N2}/0.30ppm,p-C6H15N3
  104.1182852 33.3219 104.118571 1.3446 4.97 0.8791 13 ?
  111.0916690 68.9726 111.091885 0.9092 6.23 0.8407 13 f{C6H11N2}/-0.05ppm,p-C4H15N3
  113.1073499 354.4616 113.107543 0.2652 24.80 0.9451 13 f{C6H13N2}/0.22ppm,p-C4H13N3
  115.1229154 39.5758 115.123085 1.1032 4.94 0.7363 13 f{C6H15N2}/-0.52ppm,p-C4H11N3
  128.1182410 37.6353 128.118238 1.3113 6.04 0.6813 13 f{C6H14N3}/0.13ppm,p-C4H12N2
  130.0863212 16.9076 130.086289 1.7142 2.80 0.7253 13 ?
  130.1339390 218.7542 130.133906 0.2920 15.96 0.9396 13 f{C6H16N3}/0.50ppm,p-C4H10N2
  131.0815898 16.3664 131.081543 1.7241 4.29 0.3636 12 ?
  132.1495685 70.9546 132.149505 0.9913 9.29 0.8242 13 f{C6H18N3}/0.34ppm,p-C4H8N2
  156.1495946 294.4031 156.149488 0.4163 14.47 0.9615 13 f{C8H18N3}/0.45ppm,p-C2H8N2
  173.1760685 16.3156 173.175951 1.5707 4.18 0.8022 13 f{C8H21N4}/-0.03ppm,p-C2H5N1
  198.1239389 27.6681 198.123806 1.4536 5.43 0.6593 13 ?
  199.1919019 62.8979 199.191768 1.2701 4.54 0.8791 13 f{C10H23N4}/0.90ppm,p-H3N1
  216.1354408 103.8543 216.135297 2.4337 17.70 0.3297 13 ?
  216.1718639 68.4355 216.171720 2.8311 13.19 0.4825 12 ?
  216.2183393 999.0000 216.218195 0.2359 0.00 1.0000 13 f{C10H26N5}/0.31ppm,p
PK$NUM_PEAK: 21
PK$PEAK: m/z int. rel.int.
  70.065002 12.93 12
  72.080663 21.26 21
  85.075918 19.31 19
  86.059973 29.50 29
  87.091701 102.36 102
  104.118285 33.32 33
  111.091669 68.97 68
  113.107350 354.46 354
  115.122915 39.58 39
  128.118241 37.64 37
  130.086321 16.91 16
  130.133939 218.75 218
  131.081590 16.37 16
  132.149569 70.95 70
  156.149595 294.40 294
  173.176069 16.32 16
  198.123939 27.67 27
  199.191902 62.90 62
  216.135441 103.85 103
  216.171864 68.44 68
  216.218339 999.00 999
//
